Jain Global LLC Protalix Bio Therapeutics, Inc. Transaction History
Jain Global LLC
- $7.88 Billion
- Q1 2025
A detailed history of Jain Global LLC transactions in Protalix Bio Therapeutics, Inc. stock. As of the latest transaction made, Jain Global LLC holds 81,963 shares of PLX stock, worth $136,058. This represents 0.0% of its overall portfolio holdings.
Number of Shares
81,963Holding current value
$136,058% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PLX
# of Institutions
65Shares Held
6.99MCall Options Held
227KPut Options Held
54.5K-
Jim Simons Renaissance Technologies LLC | New York, Ny1.19MShares$1.97 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny963KShares$1.6 Million0.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA859KShares$1.43 Million0.0% of portfolio
-
Northern Trust Corp Chicago, IL685KShares$1.14 Million0.0% of portfolio
-
Marshall Wace, LLP London, X0615KShares$1.02 Million0.0% of portfolio
About Protalix BioTherapeutics, Inc.
- Ticker PLX
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,753,400
- Market Cap $82.6M
- Description
- Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso fo...